• Jobs
  • Startups
  • Hire
LoginSign up

Role description

Patent Agent / Senior Patent Agent

Dualitas Therapeutics logoDualitas Therapeutics
Reports to a founder
TypeFull-time
WorkplaceOn-site
SenioritySenior
Salary$128,500–$155,000
LocationSouth San Francisco, CA
Posted9/22/2026
Legal

Patent Agent / Senior Patent Agent

Reporting to the Co-founder & Chief Scientific Officer, the Patent Agent / Senior Patent Agent will be a key leader in driving our intellectual property (IP) activities, including partnering with internal scientists and outside counsel to draft applications, prosecute patents, and set strategy. The ideal candidate for this role has a scientific background and relevant IP experience. This is a great opportunity for an IP professional eager to make a substantial impact at a rising biotech company.

Our work at Dualitas Therapeutics is guided by three Operating Principles:

  • Get Things Done Creatively as One Team — proposing solutions, aligning stakeholders, and moving work forward.
  • Advance Differentiated Medicines with Scientific Rigor — applying disciplined clinical development judgment and data-driven decision-making.
  • Operate with Urgency, Discipline and Grit — driving timelines, mitigating risks, and maintaining executional focus.

Compensation

The annual base pay range for this position is $128,500 - $155,000 and will depend on several factors, including but not limited to, the candidate’s experience, skills and competencies. The pay range reflects the Manager and Sr. Manager levels. F Title and compensation will be determined based on the candidate’s qualifications and relevant experience. This role is eligible for annual performance bonuses, equity grants, and a comprehensive benefits package that includes medical, dental, vision, retirement plan, paid time off, and other employee programs.

Relevant archetypes

Apply on Lever
Save

Company info

Dualitas Therapeutics logo

Dualitas Therapeutics

Pioneering the Future of Bispecific Antibody Therapies

Dualitas Therapeutics is a biotechnology company pioneering the future of bispecific antibody therapies for immune and inflammatory (I&I) diseases and beyond. Powered by our proprietary DualScreen™ discovery engine and a growing library of novel cell surface proximity engagers, our pipeline—including lead programs DTX-103 and DTX-102—has demonstrated compelling preclinical evidence supporting its potential to address important unmet patient needs. We offer partnering opportunities on the next generation of bispecific therapies in I&I diseases – and beyond. Notice on Fraudulent Job Offers and Recruiting Activities: Dualitas Therapeutics has been made aware of fraudulent recruiting activity in which individuals falsely claim to represent our company. These scammers may offer fake job opportunities and attempt to collect personal or financial information. All legitimate communication from Dualitas comes from email addresses ending in @dualitastx.com Our only official website is www.duali

Private companySeries A
Founded2023
Size
Unlock human wisdom
ThesisTermsPrivacy
11–50 employees
IndustryBiotechnology Research
Funding
  • Series A · Sep 16, 2025
Investors
Alexandria Venture InvestmentsChugai Venture FundQiming Venture Partners USASV Health InvestorsVersant Ventures

Claim dualitastx.com

Work at dualitastx.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.